Forget 'Best' — Let's Find Your Match
When people ask 'which is better, Zepbound or Wegovy,' they usually want a single trophy winner. But the honest, friendlier answer is that the right one depends on you — your goals, your budget, your insurance, and how your body handles each medication. A drug that's perfect for your neighbor might be the wrong call for you.
So instead of crowning a champion, let's lay out what each one does best and where the trade-offs lie. By the end you'll know which questions to bring to your doctor and roughly which direction to lean.
The Head-to-Head Numbers
In SURMOUNT-5, the trial that put these two against each other directly, Zepbound delivered approximately 20% mean weight loss compared with about 14% for Wegovy. That's a meaningful edge for tirzepatide, Zepbound's dual-action molecule, which targets two appetite pathways instead of one.
If your main goal is the greatest possible weight loss and you've struggled to get enough results elsewhere, that gap is the strongest single argument for Zepbound. It's a real, measured difference — not marketing.
| Metric | Zepbound | Wegovy |
|---|---|---|
| Mean weight loss | ~20% | ~14% |
| Molecule | Tirzepatide | Semaglutide |
| Administration | Weekly injection | Weekly injection |
SURMOUNT-5 head-to-head (seed data — please verify before relying on it)
Cost and Coverage
Efficacy is only half the equation, because the best drug is the one you can actually afford to keep taking. Pricing and insurance treatment differ between the two, and for many people that's the deciding factor. If you're sensitive to cost, or your plan covers one but not the other, that practical reality can outweigh a few percentage points of weight loss.
It's completely valid to choose Wegovy — or a cheaper option entirely — because it fits your budget and you can stay on it consistently. Consistency beats raw potency when the potent option is one you can't sustain.
Side Effects and Tolerability
Both Zepbound and Wegovy share the familiar GLP-1 side-effect profile — nausea, reduced appetite, and other GI effects that usually ease as your body adjusts. For most people these are manageable, especially with slow titration and a few eating habits dialed in.
But tolerability is personal. Some people sail through one medication and struggle with the other, and there's no way to predict it perfectly in advance. If you've had a rough time on one, that's a genuine reason to consider the other — feeling well enough to stay consistent is part of effectiveness.
The Oral Wildcard
There's a newer factor reshaping this choice: the arrival of oral GLP-1 pills around $149/month. For people who dread injections, a needle-free option can matter more than a few percentage points of weight loss. The 'best' medication is the one you'll actually take, and for the injection-averse, that might be a pill.
So when you're weighing Zepbound versus Wegovy, it's fair to add a third question to the mix: would an oral option fit your life better than either injection? It's worth raising with your clinician, because the landscape has more good choices than it did even a year ago.
The Takeaway
Zepbound leads on average weight loss in the head-to-head data, so if maximum results are your priority, it's the front-runner. But Wegovy can be the smarter pick if it's better covered, easier on your budget, or gentler on your body — and a pill can win if needles are your sticking point.
Bring your real priorities to your doctor: how much weight loss you're after, what you can afford, how you've tolerated GLP-1s before, and whether injections work for your life. The right answer is the one that fits all of those, not just the one with the biggest trial number.